Schambye Hans T.
SEC CIK 1825776 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMRA | Damora Therapeutics, Inc. | CEO, Dir | 5,382 | $26.5K | $25.0K | 8 | 2021-11-09 | 2026-01-02 |
Most active insiders at DMRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schambye Hans T. | CEO, Dir | — | $15.0K |
| 2 | Winslow Garrett | GC | — | $12.8K |
| 3 | Firmani Lori | CFO | — | $2,890 |
| 4 | Sattarzadeh Sherwin | COO | — | — |
| 5 | Bruno Julianne | Dir | — | — |
| 6 | Hewes L. Becker | Chief Medical Off | — | — |
| 7 | Fairmount Healthcare Fund II L.P. | 10% | — | — |
| 8 | Jarrett Jennifer | See Remarks, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | M - OptEx | — | +1,360 | 5,382 | +34% | — |
| D | 2026-01-06 | 2026-01-02 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | S - Sale+OE | $21.38 | -700 | 4,682 | -13% | -$15.0K |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | S - Sale+OE | $3.38 | -735 | 4,022 | -15% | -$2,484 |
| D | 2025-07-08 | 2025-07-03 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | M - OptEx | — | +1,360 | 4,757 | +40% | — |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | M - OptEx | — | +2,640 | 4,738 | +126% | — |
| D | 2025-01-07 | 2025-01-03 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | S - Sale+OE | $5.60 | -1,341 | 3,397 | -28% | -$7,510 |
| 2022-03-23 | 2022-03-22 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | P - Purchase | $2.15 | +5,000 | 52.4K | +11% | +$10.8K | |
| 2021-11-10 | 2021-11-09 | DMRA | Damora Therapeutics, Inc. | Schambye Hans T. | CEO, Dir | P - Purchase | $3.50 | +4,500 | 47.4K | +10% | +$15.8K |
Purchase Sale Sale after option exercise All abbreviations